InvestorsHub Logo
Replies to #27893 on Biotech Values

DewDiligence

04/30/06 5:10 PM

#27913 RE: DewDiligence #27893

Oops—I noticed a typo I failed to remove in the GTCB CC transcript in #27899. About one-quarter of the way down, the transcript says:

“Labels for plasma-derived products indicate a retirement for hepatitis A & B vaccination prior to use. Hepatitis vaccination would not be necessary with ATryn.”

The word “retirement” should of course be “requirement.”

CC transcripts are a handy tool, but they are usually rife with typos and more serious errors. I hardly ever rely on transcripts to the exclusion of the live calls.